國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Drug-induced lung injury

Aoshiba, Kazutetsu.

Drug-induced lung injury

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Drug-induced lung injuryedited by Masayuki Hanaoka, Hiroyuki Nakamura, Kazutetsu Aoshiba.
其他作者:	Hanaoka, Masayuki.
出版者:	Singapore :Springer Singapore :2018.
面頁冊數:	viii, 215 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	LungsWounds and injuries.
電子資源:	http://dx.doi.org/10.1007/978-981-10-4466-3
ISBN:	9789811044663$q(electronic bk.)

Drug-induced lung injury
Drug-induced lung injury[electronic resource] /edited by Masayuki Hanaoka, Hiroyuki Nakamura, Kazutetsu Aoshiba. - Singapore :Springer Singapore :2018. - viii, 215 p. :ill., digital ;24 cm. - Respiratory disease series: diagnostic tools and disease managements,2509-5552. - Respiratory disease series: diagnostic tools and disease managements..

Part I　Definition, Pathogenesis, and Epidemiology -- 1. Definition, Pathogenesis and Epidemiology: What is DLI? -- 2. Epidemiology and Risk Factors of Drug-Induced Lung Disease: What are the prevalence and risk factors of DLI? -- 3. Clinical Characteristics of DLI: What are the clinical features of DLI? -- Part II　Diagnosis -- 4. Diagnostic Approach for DLI: How is DLI diagnosed? -- 5. Blood tests for the diagnosis and/or management of DLI: What are the clinical significances of KL-6, SP-A, SP-D and DLST in DLI? -- 6. Imaging features of drug-induced interstitial lung disease: How HRCT of DLI is interpreted? -- 7. Pathology of DLI: What is the pathological significance of DLI? -- 8. Differential Diagnosis of DLI: What are the differential diagnoses of DLI? -- Part II　Treatment -- 9. Therapeutic Strategies for DLI: How should DLI be treated? -- Part IV　Drugs Causing DLI -- 10. DLI induced by non-molecular target antineoplastic drugs: What are the characteristics of DLI in non-molecular target antineoplastic drugs? -- 11. DLI induced by Molecular Target Antineoplastic Drug: What are the characteristics of DLI in molecular target antineo-plastic drugs? -- 12. DLI caused by disease-modifying antirheumatic drugs: What are the characteristics of DLI by disease-modifying antirheumatic drugs? -- 13. DLI Induced by Herbal Medicine: What are the characteristics of DLI due to herbal medicines? -- 14. DLI induced by Antiarrhythmic Drug and Antimicrobial Drug: What are the characteristics of DLI in antiarrhythmic drugs and antimicrobial drugs?

ISBN: 9789811044663$q(electronic bk.)

Standard No.: 10.1007/978-981-10-4466-3doiSubjects--Topical Terms:

512208
Lungs
--Wounds and injuries.

LC Class. No.: RD539

Dewey Class. No.: 616.24

Drug-induced lung injury
LDR:02580nmm a2200313 a 4500 001 528901
003 DE-He213
005 20180621114155.0
006 m d
007 cr nn 008maaau
008 181030s2018 si s 0 eng d
020 $a 9789811044663$q(electronic bk.)
020 $a 9789811044656$q(paper)
024 7 $a 10.1007/978-981-10-4466-3 $2 doi
035 $a 978-981-10-4466-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RD539
072 7 $a MJL $2 bicssc
072 7 $a MED079000 $2 bisacsh
082 0 4 $a 616.24 $2 23
090 $a RD539 $b .D794 2018
245 0 0 $a Drug-induced lung injury $h [electronic resource] / $c edited by Masayuki Hanaoka, Hiroyuki Nakamura, Kazutetsu Aoshiba.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2018.
300 $a viii, 215 p. : $b ill., digital ; $c 24 cm.
490 1 $a Respiratory disease series: diagnostic tools and disease managements, $x 2509-5552
505 0 $a Part I　Definition, Pathogenesis, and Epidemiology -- 1. Definition, Pathogenesis and Epidemiology: What is DLI? -- 2. Epidemiology and Risk Factors of Drug-Induced Lung Disease: What are the prevalence and risk factors of DLI? -- 3. Clinical Characteristics of DLI: What are the clinical features of DLI? -- Part II　Diagnosis -- 4. Diagnostic Approach for DLI: How is DLI diagnosed? -- 5. Blood tests for the diagnosis and/or management of DLI: What are the clinical significances of KL-6, SP-A, SP-D and DLST in DLI? -- 6. Imaging features of drug-induced interstitial lung disease: How HRCT of DLI is interpreted? -- 7. Pathology of DLI: What is the pathological significance of DLI? -- 8. Differential Diagnosis of DLI: What are the differential diagnoses of DLI? -- Part II　Treatment -- 9. Therapeutic Strategies for DLI: How should DLI be treated? -- Part IV　Drugs Causing DLI -- 10. DLI induced by non-molecular target antineoplastic drugs: What are the characteristics of DLI in non-molecular target antineoplastic drugs? -- 11. DLI induced by Molecular Target Antineoplastic Drug: What are the characteristics of DLI in molecular target antineo-plastic drugs? -- 12. DLI caused by disease-modifying antirheumatic drugs: What are the characteristics of DLI by disease-modifying antirheumatic drugs? -- 13. DLI Induced by Herbal Medicine: What are the characteristics of DLI due to herbal medicines? -- 14. DLI induced by Antiarrhythmic Drug and Antimicrobial Drug: What are the characteristics of DLI in antiarrhythmic drugs and antimicrobial drugs?
650 0 $a Lungs $x Wounds and injuries. $3 512208
650 0 $a Drugs $x Side effects. $3 375432
650 1 4 $a Medicine & Public Health. $3 273799
650 2 4 $a Pneumology/Respiratory System. $3 274253
700 1 $a Hanaoka, Masayuki. $3 801596
700 1 $a Nakamura, Hiroyuki. $3 738248
700 1 $a Aoshiba, Kazutetsu. $3 738249
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Respiratory disease series: diagnostic tools and disease managements. $3 801597
856 4 0 $u http://dx.doi.org/10.1007/978-981-10-4466-3
950 $a Medicine (Springer-11650)